603566 logo

Pulike Biological Engineering, Inc. Stock Price

SHSE:603566 Community·CN¥4.7b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

603566 Share Price Performance

CN¥0
-13.34 (-100.00%)
CN¥0
-13.34 (-100.00%)
Price CN¥0

603566 Community Narratives

There are no narratives available yet.

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Flawless balance sheet and undervalued.

1 Risk
4 Rewards

Pulike Biological Engineering, Inc. Key Details

CN¥1.1b

Revenue

CN¥450.4m

Cost of Revenue

CN¥653.5m

Gross Profit

CN¥509.8m

Other Expenses

CN¥143.7m

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
Dec 01, 2025
0.42
59.20%
13.02%
0%
View Full Analysis

About 603566

Founded
1995
Employees
1551
CEO
Wei Hu
WebsiteView website
www.pulike.com.cn

Pulike Biological Engineering, Inc. engages in the research, development, production, and sale of veterinary biological products, chemical drugs, and traditional Chinese veterinary drugs. The company offers vaccines, antibodies, and medicines for swine and poultry, as well as disinfectants. Pulike Biological Engineering, Inc. was founded in 1995 and is headquartered in Luoyang, China.

Recent 603566 News & Updates

Recent updates

No updates